Vineet Bhatia
Fortis Healthcare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vineet Bhatia.
Indian heart journal | 2014
Upendra Kaul; Arvind Sethi; Priyadarshini Arambam; Ashraf Omar; R. Keshava; Sanjeeb Roy; Shuvanan Ray; Rakesh Jaswal; Ripan K. Gupta; Rakesh Sapra; Rane Sandip Keshav; Rajpal Singh; Vineet Bhatia; Vinay Sanghi; Arun Chopra
BACKGROUND Clopidogrel has been the only available antiplatelet drug used along with aspirin in patients of ACS. In recent years 2 new antiplatelet drugs (Prasugrel and Ticagrelor) have become available. Prasugrel in the dose of 10 mg OD has been found to be more efficacious but with increased risk of major bleeding. For this reason it has not gained widespread usage in ACS patients undergoing PCI. There are no systematic data on the use of Prasugrel in Indian population. METHOD This is a prospective, multicentric, hospital registry of 1000 patients with ACS undergoing PCI who were administered Prasugrel. The primary safety endpoint of this study was major and minor bleeding while the efficacy endpoint is the composite of CV death, nonfatal MI, nonfatal stroke up to 30 days after PCI. Patients with high bleeding risk were excluded. RESULTS Most patients (91%) received loading dose of Prasugrel along with the maintenance dose getting according to the defined protocol. Patients were followed up to 30 days post procedure. Primary efficacy end point was reached in 3 patients only with two of them dying due to possible stent thrombosis and the third requiring revascularization of the target vessel for stent thrombosis. One major and 19 minor bleeding complications were recorded, with access site bleeding in 0.7% & non-access site bleeding in 1.2% of the subjects. CONCLUSION Prasugrel was found to be effective & not associated with a high incidence of bleeding in the high risk ACS patients when those at a high bleeding risk were excluded.
Heart Views | 2010
Vineet Bhatia; Parneesh Arora; Ak Pandey; Upendra Kaul
Type IV dual left anterior descending (LAD) coronary artery is a rare anomaly and was detected incidentally during a routine coronary angiogram. The article discusses the types of dual LAD and their clinical implications.
Heart Research - Open Journal | 2017
Vineet Bhatia; Parneesh Arora; Gagandeep Kaur; Upendera Kaul
Dyslipidemia alone has been considered as one of the major modifiable risk factor for cardiovascular diseases (CVD) accounting for 50% of the 1st myocardial infarction (MI) cases worldwide.1 A recent epidemiological survey on prevalence of lipid abnormalities of the Indian population by Indian Council of Medical Research-India Diabetes Study (ICMR-INDIAB), has shown that 79% of Indian subjects above 20 years of age have abnormalities in at least one of the lipid parameters.2 In this survey, the most commonly found lipid abnormality was low-high density lipoprotein cholesterol (low HDL-C) in 72% subjects followed by high triglycerides (TG) in 29.5% subjects and then high low-density lipoprotein cholesterol (LDL-C) in 11.8% subjects.3 Prevalence of dyslipidemia is high in India, which calls for urgent lifestyle and pharmacological intervention strategies to prevent and manage this important cardiovascular risk factor.
Heart Research - Open Journal | 2016
Vineet Bhatia; Parneesh Arora; Ripen Gupta; Upendra Kaul; Principal Consultant; Consultant; Bhatia; Prabha Arora; R. P. Gupta
Revascularization of ectatic coronary arteries in the setting of acute myocardial infarction pos- es great challenges for the operator. We report a case, where a peripheral renal stent was used successfully to treat the clinical situation.
Heart Research - Open Journal | 2016
Vineet Bhatia; Anil Minocha; Parneesh Arora; Upendra Kaul; Vasant Kunj; Consultant
Carcinoid Heart Disease (CHD) is an important and rare cause of acquired valvular heart disease. Clinical examination supplemented with Echocardiographic evaluation may give the first clue towards an under lying carcinoid tumor. We report a case with classical Echocar - diographic features of carcinoid heart disease.
Heart Research - Open Journal | 2015
Vineet Bhatia; Parneesh Arora; Anil Minocha
Page 51 The Saddle thrombus is a rare condition characterized by presence of a large thrombus which straddles the main pulmonary arterial trunk and its bifurcation leading to acute massive Pulmonary Embolism (PE). Its incidence among patients diagnosed with PE is approximately 2.6%.1 Saddle PE frequently results in significant hemodynamic instability and signals the potential for imminent hemodynamic collapse. This is rarely seen on Trans-thoracic echocardiography (TTE). We recently came across a patient who presented with breathlessness following transatlantic air travel. His TTE (routine and 3D) revealed a saddle thrombus in the main pulmonary arterial trunk extending into its two main branches (Figures 1 and 2). A CT pulmonary angiogram confirmed the same (Figure 3). He was subsequently successfully thrombolyzed and made an uneventful recovery.
Indian heart journal | 2014
Parneesh Arora; Vineet Bhatia; M. Arora; Upendra Kaul
Adenosine is commonly used as a pharmacological agent in myocardial perfusion imaging, as an antiarrhythmic agent, and in Cath Lab. during PCI for treating no reflow phenomenon. Coronary spasm has been reported following adenosine injection during stress imaging. We report a rare complication with ST segment elevation, following adenosine injection, given for treatment of supraventricular tachycardia.
International Journal of Cardiology | 2007
Vineet Bhatia; Ajay Mittal; Ashok K Parida; Rajesh Talwar; Upendra Kaul
International Journal of Cardiology | 2007
Vineet Bhatia
International Journal of Cardiology | 2007
Vineet Bhatia; Ashok K Parida; Anand K. Pandey; Upendra Kaul